Glomerulonephritis (GN) days

This meeting is a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis (GN) Clinical Study Group (CSG), showcasing developments in the field of inflammatory renal disease, advancements in basic science, registries, therapeutic targets and clinical trials in glomerulonephritis. 

By attending the meeting, participants will gain an in-depth understanding on the pathological mechanisms and therapeutic targets in Glomerulonephritis. Topics will be reviewed and delivered through interactive lectures, case based and panel discussions. 

This meeting is a collaboration between scientists, clinicians, trialist and pharm showcasing pioneering developments in inflammatory renal diseases. 

By attending the meeting, you will:

• Gain an increased awareness of developments in refining definitions of disease entities in inflammatory renal diseases
• Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis
• Enhance your knowledge of management strategies for Glomerulonephritis
• Be aware of developments in techniques in identifying renal autoimmune diseases
• Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis 
• Gain updates on UK Kidney Research GN Clinical study Group

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

We would like to thank our sponsors and exhibitors Britannia Pharmaceuticals and CSL Vifor for their support of this meeting. This activity has also been supported by Alentis Therapeutics, Alpine Immune Sciences, argenx, Arrowhead Pharmaceutical, Chinook Therapeutics, Otsuka, Vera Therapeutics in the form of educational grants.

Due to this funding, the Nephrology Section is pleased to offer this event at a subsidised fee for participants.